Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study
- PMID: 19940278
- DOI: 10.1161/STROKEAHA.109.564708
Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study
Abstract
Background and purpose: Few studies have shown the association between glucose tolerance status defined by a 75-g oral glucose tolerance test and the development of different types of cardiovascular disease.
Methods: A total of 2421 community-dwelling Japanese subjects aged 40 to 79 years who underwent the oral glucose tolerance test were followed up for 14 years.
Results: In multivariable analysis, the risks of ischemic stroke in both sexes and coronary heart disease (CHD) in women were significantly higher in subjects with diabetes determined by the World Health Organization criteria than in those with normal glucose tolerance even after adjustment for other confounding factors, but such association was not seen for CHD in men (ischemic stroke: adjusted hazard ratio [HR]=2.54, P=0.002 in men; adjusted HR=2.02, P=0.03 in women; CHD: adjusted HR=1.26, P=0.47 in men; adjusted HR=3.46, P=0.002 in women). Similar associations were observed for fasting plasma glucose levels of >or=7.0 mmol/L (ischemic stroke: adjusted HR=2.15, P=0.03 in men; adjusted HR=2.10, P=0.045 in women; CHD: adjusted HR=1.29, P=0.47 in men; adjusted HR=3.83, P=0.003 in women) and for 2-hour postload glucose levels of >or=11.1 mmol/L (ischemic stroke: adjusted HR=2.71, P=0.003 in men; adjusted HR=2.19, P=0.03 in women; CHD: adjusted HR=1.58, P=0.16 in men; adjusted HR=4.44, P<0.001 in women). The age-adjusted incidences of ischemic stroke and CHD did not significantly increase in subjects with impaired fasting glycemia or impaired glucose tolerance in either sex.
Conclusions: Our findings suggest that diabetes is an independent risk factor for ischemic stroke in both sexes and CHD in women in the Japanese population.
Similar articles
-
Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study.Atherosclerosis. 2015 Sep;242(1):199-204. doi: 10.1016/j.atherosclerosis.2015.07.014. Epub 2015 Jul 10. Atherosclerosis. 2015. PMID: 26204496
-
Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study.Atherosclerosis. 2014 Apr;233(2):343-348. doi: 10.1016/j.atherosclerosis.2014.01.005. Epub 2014 Jan 21. Atherosclerosis. 2014. PMID: 24530960
-
Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study.Am J Epidemiol. 2012 Nov 15;176(10):856-64. doi: 10.1093/aje/kws178. Epub 2012 Oct 25. Am J Epidemiol. 2012. PMID: 23100249
-
[The Funagata study--impaired glucose tolerance is a risk factor for stroke in a Japanese sample].Nihon Rinsho. 2010 May;68(5):843-6. Nihon Rinsho. 2010. PMID: 20446580 Review. Japanese.
-
Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.PLoS Med. 2010 May 25;7(5):e1000278. doi: 10.1371/journal.pmed.1000278. PLoS Med. 2010. PMID: 20520805 Free PMC article. Review.
Cited by
-
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19. J Atheroscler Thromb. 2024. PMID: 38123343 Free PMC article. No abstract available.
-
NT-proBNP and cardiovascular event risk in individuals with prediabetes undergoing cardiovascular evaluation.Diabetes Res Clin Pract. 2023 Nov;205:110923. doi: 10.1016/j.diabres.2023.110923. Epub 2023 Sep 27. Diabetes Res Clin Pract. 2023. PMID: 37774978 Free PMC article.
-
Evaluation of High Intracranial Plaque Prevalence in Type 2 Diabetes Using Vessel Wall Imaging on 7 T Magnetic Resonance Imaging.Brain Sci. 2023 Jan 28;13(2):217. doi: 10.3390/brainsci13020217. Brain Sci. 2023. PMID: 36831760 Free PMC article.
-
Sex-Related Differences in Sitagliptin Treatment in Type 2 Diabetes: Results from the PROLOGUE Trial.Med Sci Monit. 2022 Nov 29;28:e938030. doi: 10.12659/MSM.938030. Med Sci Monit. 2022. PMID: 36444134 Free PMC article.
-
Real-World Safety and Effectiveness of Canagliflozin Treatment for Type 2 Diabetes Mellitus in Japan: SAPPHIRE, a Long-Term, Large-Scale Post-Marketing Surveillance.Adv Ther. 2022 Jan;39(1):674-691. doi: 10.1007/s12325-021-01984-4. Epub 2021 Dec 2. Adv Ther. 2022. PMID: 34853985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical